Community Spotlight: Susan G. Komen New England

Susan G Komen logo

Komen addresses breast cancer through community outreach, research, advocacy and global intervention and is the largest nonprofit funder of breast cancer research, second only to the U.S. Government. Join us and make a difference with Komen’s #BoldGoal and find out how to be #MoreThanPinkbelow!

Breast Cancer accounts for nearly 1 in 3 cancers diagnosed in women in the United States. Aside from skin cancer, it is the most common cancer among U.S. women.

National Breast Cancer Awareness Month

 

Susan G Komen survivor

This October marks the 32nd anniversary of National Breast Cancer Awareness Month. The importance of early detection helps to save lives. Breast cancer is a widespread disease that knows no boundaries and does not discriminate. Since the inception of Susan G. Komen, progress has been made but there is still more to be done. While breast cancer death rates have declined steadily (from 32 deaths per 100,000 in 1982 to 20 deaths per 100,000 in 2013), 40,000 women and men still die each year from breast cancer, and that is what must change. Annually, nearly 3,000 women and men will be diagnosed with breast cancer in Connecticut alone.

 

This year, Susan G. Komen is drawing increased attention to metastatic breast cancer (MBC) in their efforts to achieve the Bold Goal to reduce breast cancer deaths in the U.S. by 50 percent by 2026. Metastatic breast cancer – which is breast cancer that has spread to the lungs, liver, brain or bones – is responsible for the vast majority of those deaths. The focus this fall (and ongoing) is intended to drive urgency and attention to the forms of breast cancer that still kill. This education is especially important for those who believe that breast cancer is “easily treated” or always curable.

 

To continue reading this article Click Here or head over to our blog DrivenCT for more content like this!

Date Posted: October 6, 2017